Literature DB >> 26841192

Giant cell hepatitis with autoimmune hemolytic anemia in a Korean infant.

Myung Hyun Cho1, Hee Sun Park2, Hye Seung Han3, Sun Hwan Bae1.   

Abstract

Giant cell hepatitis (GCH) with autoimmune hemolytic anemia (AHA) is a very rare disease characterized by early onset and severe clinical manifestations, including immune hemolytic anemia and hepatitis with cholestasis. The prognosis is poor despite aggressive immunosuppressive therapy. We report here the first case of GCH with AHA in East Asia. A 2-month-old boy was admitted with jaundice. Blood test indicated abnormal liver function and low hemoglobin. Direct Coombs test and several autoantibodies associated with liver disease were positive, and liver biopsy was consistent with GCH. He was treated with prednisolone and ursodeoxycholic acid, and at the time of writing was in clinical and biochemical remission after prednisolone was stopped.
© 2016 Japan Pediatric Society.

Entities:  

Keywords:  autoimmune hemolytic anemia; giant cell; hepatitis; prednisolone; ursodeoxycholic acid

Mesh:

Year:  2016        PMID: 26841192     DOI: 10.1111/ped.12874

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  1 in total

1.  Successful Treatment of a Korean Infant with Giant Cell Hepatitis with Autoimmune Hemolytic Anemia Using Rituximab.

Authors:  Young Ho Kim; Ju Whi Kim; Eun Joo Lee; Gyeong Hoon Kang; Hyoung Jin Kang; Jin Soo Moon; Jae Sung Ko
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.